Landec Corporation provided revenue guidance for the full year fiscal 2023. For the year, the company expects Lifecore segment revenue of range of $122 million to $126 million (+12% to +15%).
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
5.2 USD | -1.33% |
|
-12.01% | -15.99% |
Jun. 11 | 22NW Fund Submits Shareholder Proposals to Lifecore Biomedical | CI |
May. 20 | 22NW Fund Nominates Candidates to the Board of Lifecore Biomedical | CI |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-15.99% | 159M | |
+41.47% | 630B | |
-7.15% | 350B | |
+18.77% | 328B | |
+8.79% | 298B | |
+17.45% | 246B | |
+0.12% | 225B | |
+10.40% | 218B | |
+3.68% | 160B | |
-4.38% | 156B |
- Stock Market
- Equities
- LFCR Stock
- News Lifecore Biomedical, Inc.
- Landec Corporation Provides Revenue Guidance for the Full Year Fiscal 2023